Fajardo RA

Idioma: Español
Referencias bibliográficas: 19
Paginas: 554-557
Archivo PDF: 386.17 Kb.

RESUMEN

La fatiga postinfecciosa es un cuadro frecuente en el consultorio, pero suele subestimarse. Ocurre tras infecciones como la influenza, SARS-CoV-2 o la mononucleosis, y se manifiesta con fatiga, trastornos del sueño, disnea leve y dificultad para concentrarse, sin hallazgos clínicos relevantes. Esta revisión ofrece una síntesis práctica sobre su presentación clínica, fisiopatología, diagnóstico razonado y manejo ambulatorio, destacando el papel del internista como figura clave en el acompañamiento terapéutico.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Komaroff AL, Lipkin WI. Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis ofpostacute COVID-19 syndrome. Trends Mol Med. 2021; 27 (9):895-906.

2. National Institute for Health and Care Excellence (NICE). Myalgicencephalomyelitis (or encephalopathy)/chronic fatigue syndrome:diagnosis and management. London: NICE; 2021 [Cited 2025 April18]. Available in: https://www.nice.org.uk/guidance/ng206

3. Centers for Disease Control and Prevention (CDC). Post-COVIDconditions: information for healthcare providers. Atlanta: CDC;2021 [Cited 2025 April 18]. Available in: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-index.html

4. World Health Organization (WHO). A clinical case definition of postCOVID-19 condition by a Delphi consensus [Internet]. Geneva:WHO; 2021 [Cited 2025 April 18]. Available in: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1

5. NHS. Post-viral fatigue: a guide to management. NHS; 2021 [Cited2025 April 18]. Available in: https://www.nhs.uk/conditions/postviral-fatigue

6. Crook H, Raza S, Nowell J, Young M, Edison P. Long covidmechanisms,risk factors, and management. BMJ. 2021; 374: n1648.doi: 10.1136/bmj.n1648.

7. Townsend L, Dyer AH, Jones K et al. Persistent fatigue followingSARS-CoV-2 infection is common and independent of severity ofinitial infection. PLoS One. 2020; 15 (11): e0240784.

8. Harvey SB, Wadsworth M, Wessely S, Hotopf M. Etiology of chronicfatigue syndrome: testing popular hypotheses using a national birthcohort study. Psychosom Med. 2008; 70 (6): 488-495.

9. Komaroff AL. Advances in understanding the pathophysiology ofchronic fatigue syndrome. JAMA. 2019; 322 (6): 499-500.

10. Fukuda K, Straus SE, Hickie I et al. The chronic fatigue syndrome: acomprehensive approach to its definition and study. Ann Intern Med.1994; 121 (12): 953-959.

11. Dantzer R, Heijnen CJ, Kavelaars A, Laye S, Capuron L. Theneuroimmune basis of fatigue. Trends Neurosci. 2014; 37 (1):39-46.

12. Nacul LC, Lacerda EM, Pheby D et al. Prevalence of myalgicencephalomyelitis/chronic fatigue syndrome in three regions ofEngland: a repeated cross-sectional study in primary care. BMC Med.2011; 9: 91.

13. Soriano JB, Murthy S, Marshall JC et al. A clinical case definition ofpost COVID-19 condition by a Delphi consensus. Lancet Infect Dis.2022; 22 (4): e102-e107.

14. Davis HE, Assaf GS, McCorkell L et al. Characterizing long COVIDin an international cohort: 7 months of symptoms and their impact.EClinicalMedicine. 2021; 38: 101019.

15. Proal AD, VanElzakker MB. Long COVID or post-acute sequelae ofCOVID-19 (PASC): an overview of biological factors that may contributeto persistent symptoms. Front Microbiol. 2021; 12: 698169.

16. Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19syndrome. Nat Med. 2021; 27 (4): 601-615.

17. Sudre CH, Murray B, Varsavsky T et al. Attributes and predictors oflong COVID. Nat Med. 2021; 27 (4): 626-631.

18. Rando HM, Bennett TD, Byrd JB et al. Challenges in definingLong COVID: striking differences across literature, electronichealth records, and patient-reported information. medRxiv.2021: 2021.03.20.21253896. Available in: https://doi.org/10.1101/2021.03.20.21253896

19. Michelen M, Manoharan L, Elkheir N et al. Characterising longCOVID: a living systematic review. BMJ Glob Health. 2021; 6 (9):e005427.